Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 08, 2026 Filed Jun 10, 2026 20:31 UTC |
Francis Knuettel IIDirector
|
GrantStock Options (Right to Buy) · Derivative | 500,000 | Not disclosed Strike: $0.25 | Not disclosed |
DisclosureSEC source: 0001731122-26-000834 · ownership.xml · derivative · entry 1 Francis Knuettel II · CIK 0001433316 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2036-06-08 F1 · security: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan, and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested. F1 · price: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan, and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested. F1 · derivative.exercise_date: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan, and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 20:31 UTC |
Scott Martin PInterim CFO
|
GrantStock Options (Right to Buy) · Derivative | 700,000 | Not disclosed Strike: $0.25 | Not disclosed |
DisclosureSEC source: 0001731122-26-000832 · ownership.xml · derivative · entry 1 Scott Martin P · CIK 0001306996 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 700,000 Underlying: Common Stock · 700,000 shares Expires 2036-06-08 F1 · security: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested. F1 · price: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested. F1 · derivative.exercise_date: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 20:31 UTC |
Fore Thomas ButlerDirector
|
GrantStock Options (Right to Buy) · Derivative | 500,000 | Not disclosed Strike: $0.25 | Not disclosed |
DisclosureSEC source: 0001731122-26-000836 · ownership.xml · derivative · entry 1 Fore Thomas Butler · CIK 0001715594 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2036-06-08 F1 · security: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested. F1 · price: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested. F1 · derivative.exercise_date: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 20:31 UTC |
Caple Frederick WilliamDirector
|
GrantStock Options (Right to Buy) · Derivative | 500,000 | Not disclosed Strike: $0.25 | Not disclosed |
DisclosureSEC source: 0001731122-26-000835 · ownership.xml · derivative · entry 1 Caple Frederick William · CIK 0001978199 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2036-06-08 F1 · security: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested. F1 · price: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested. F1 · derivative.exercise_date: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 20:31 UTC |
Cobb Brady JamesDirector · Interim CEO
|
GrantStock Options (Right to Buy) · Derivative | 925,000 | Not disclosed Strike: $0.25 | Not disclosed |
DisclosureSEC source: 0001731122-26-000833 · ownership.xml · derivative · entry 1 Cobb Brady James · CIK 0002112459 · Director · Interim CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 925,000 Underlying: Common Stock · 925,000 shares Expires 2036-06-08 F1 · security: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested. F1 · price: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested. F1 · derivative.exercise_date: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested. Read SEC document |
| June 08, 2026 Filed Jun 15, 2026 20:30 UTC |
Bondurant Michael BreenChief Operating Officer
|
GrantStock Options (Right to Buy) · Derivative | 800,000 | Not disclosed Strike: $0.25 | Not disclosed |
DisclosureSEC source: 0001731122-26-000860 · ownership.xml · derivative · entry 1 Bondurant Michael Breen · CIK 0002140335 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 800,000 Underlying: Common Stock · 800,000 shares Expires 2036-06-08 F1 · security: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested. F1 · price: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested. F1 · derivative.exercise_date: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested. Read SEC document |
| July 31, 2025 Filed Oct 10, 2025 16:31 UTC |
Devereux William TChief Financial Officer
|
GrantWarrants · Derivative | 1,000,000 | Not disclosed Strike: $0.80 | Not disclosed |
DisclosureSEC source: 0001731122-25-001372 · ownership.xml · derivative · entry 1 Devereux William T · CIK 0002089296 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Stock · 1,000,000 shares Expires 2030-07-31 F1 · security: The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants are fully vested. F1 · price: The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants are fully vested. Read SEC document |
| July 31, 2025 Filed Oct 14, 2025 16:15 UTC |
Meissner William R.President and CMO · 10% owner
|
GrantWarrants · Derivative | 750,000 | Not disclosed Strike: $0.80 | Not disclosed |
DisclosureSEC source: 0001731122-25-001374 · ownership.xml · derivative · entry 1 Meissner William R. · CIK 0001489090 · President and CMO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 750,000 Underlying: Common Stock · 750,000 shares Expires 2030-07-31 F1 · security: The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants are fully vested. F1 · price: The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants are fully vested. Read SEC document |
| July 31, 2025 Filed Oct 15, 2025 20:16 UTC |
Yorke Justin WDirector
|
GrantWarrants · Derivative | 750,000 | Not disclosed Strike: $0.80 | Not disclosed |
DisclosureSEC source: 0001731122-25-001383 · ownership.xml · derivative · entry 1 Yorke Justin W · CIK 0001361896 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 750,000 Underlying: Common Stock · 750,000 shares Expires 2030-07-31 F1 · security: The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants are fully vested. F1 · price: The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants are fully vested. Read SEC document |
| July 31, 2025 Filed Oct 15, 2025 20:20 UTC |
Nistico RobertDirector · CEO and Chairman · 10% owner
|
GrantWarrants · Derivative | 750,000 | Not disclosed Strike: $0.80 | Not disclosed |
DisclosureSEC source: 0001731122-25-001386 · ownership.xml · derivative · entry 1 Nistico Robert · CIK 0001797597 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 750,000 Underlying: Common Stock · 750,000 shares Expires 2030-07-31 F1 · security: The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants shall vest as follows: one third upon completion of the repayment by the Company of the UpTime Investors and the other two thirds vesting quarterly over a two-year period with the first vesting date on October 31, 2025. F1 · price: The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants shall vest as follows: one third upon completion of the repayment by the Company of the UpTime Investors and the other two thirds vesting quarterly over a two-year period with the first vesting date on October 31, 2025. Read SEC document |
| July 31, 2025 Filed Oct 20, 2025 20:20 UTC |
Caple Frederick WilliamDirector · 10% owner
|
GrantWarrants · Derivative | 750,000 | Not disclosed Strike: $0.80 | Not disclosed |
DisclosureSEC source: 0001731122-25-001406 · ownership.xml · derivative · entry 1 Caple Frederick William · CIK 0001978199 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · SNS Universal Solutions LLC Disclosed balance after: 750,000 Underlying: Common Stock · 750,000 shares Expires 2030-07-31 F1 · security: The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants are fully vested. F1 · price: The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants are fully vested. F2 · ownership.nature: SNS Universal Solutions LLC is an entity which the Reporting Person controls. Read SEC document |
| July 31, 2025 Filed Oct 31, 2025 20:15 UTC |
Fore Thomas ButlerDirector · 10% owner
|
GrantWarrants · Derivative | 750,000 | Not disclosed Strike: $0.80 | Not disclosed |
DisclosureSEC source: 0001731122-25-001461 · ownership.xml · derivative · entry 1 Fore Thomas Butler · CIK 0001715594 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By TBF Holdings LLC Disclosed balance after: 750,000 Underlying: Common Stock · 750,000 shares Expires 2030-07-31 F1 · security: The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants are fully vested. F1 · price: The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants are fully vested. F2 · ownership.nature: TBF Holdings LLC is an entity which the Reporting Person controls. Read SEC document |
| March 20, 2025 Filed Oct 15, 2025 16:16 UTC |
Devereux William TChief Financial Officer
|
GrantStock Options (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $6.04 | $0.00 |
DisclosureSEC source: 0001731122-25-001384 · ownership.xml · derivative · entry 1 Devereux William T · CIK 0002089296 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2030-03-20 F1 · security: The stock options vest as follows: 5,000 are vested, 5,000 vest on March 20, 2026 and 5,000 vest on March 20, 2027, subject in each case to continued services to the Company as of each applicable vesting date. F2 · security: Gives effect to a reverse stock split of 1-for-40 effective March 27, 2025. F1 · derivative.exercise_date: The stock options vest as follows: 5,000 are vested, 5,000 vest on March 20, 2026 and 5,000 vest on March 20, 2027, subject in each case to continued services to the Company as of each applicable vesting date. Read SEC document |
| April 26, 2024 Filed May 6, 2024 18:22 UTC |
Ivancsits Julius PaulChief Financial Officer
|
GrantStock options · Derivative | 750,000 | $0.00 Strike: $0.33 | $0.00 |
DisclosureSEC source: 0001731122-24-000741 · ownership.xml · derivative · entry 1 Ivancsits Julius Paul · CIK 0002022414 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 750,000 Underlying: Common stock · 750,000 shares Expires 2034-04-26 F1 · derivative.exercise_date: The options are being issued in connection with appointment as the chief financial officer of the Company, pursuant to the 2020 Long-Term Incentive Compensation Plan. 250,000 of the options vested on April 24, 2024, with the remaining options vesting in two equal annual installments beginning on April 24, 2025. F1 · balance_after: The options are being issued in connection with appointment as the chief financial officer of the Company, pursuant to the 2020 Long-Term Incentive Compensation Plan. 250,000 of the options vested on April 24, 2024, with the remaining options vesting in two equal annual installments beginning on April 24, 2025. Read SEC document |
| April 19, 2024 Filed Oct 20, 2025 20:15 UTC |
Caple Frederick WilliamDirector
|
GrantStock Options (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $13.60 | $0.00 |
DisclosureSEC source: 0001731122-25-001405 · ownership.xml · derivative · entry 2 Caple Frederick William · CIK 0001978199 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · SNS Universal Solutions LLC Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-04-19 F2 · security: The stock options shall be exercisable for a 3-year period, and shall vest as follows: 75,000 immediately (125,000 already vested) and 50,000 per quarter for the next 8 quarters. F3 · security: Gives effect to a reverse stock split of 1-for-40 effective March 27, 2025. F1 · derivative.exercise_date: The grant of the Issuer's restricted common stock was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The shares of restricted common stock are fully vested. F4 · ownership.nature: SNS Universal Solutions LLC is an entity which the Reporting Person controls. Read SEC document |
| April 19, 2024 Filed Oct 20, 2025 20:15 UTC |
Caple Frederick WilliamDirector
|
GrantCommon Stock | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001731122-25-001405 · ownership.xml · nonDerivative · entry 1 Caple Frederick William · CIK 0001978199 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · SNS Universal Solutions LLC Disclosed balance after: 1,875 F1 · security: The grant of the Issuer's restricted common stock was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The shares of restricted common stock are fully vested. F3 · shares: Gives effect to a reverse stock split of 1-for-40 effective March 27, 2025. F3 · balance_after: Gives effect to a reverse stock split of 1-for-40 effective March 27, 2025. F4 · ownership.nature: SNS Universal Solutions LLC is an entity which the Reporting Person controls. Read SEC document |
| March 05, 2024 Filed Oct 15, 2025 20:18 UTC |
Nistico RobertDirector · CEO and Chairman
|
GrantCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001731122-25-001385 · ownership.xml · nonDerivative · entry 1 Nistico Robert · CIK 0001797597 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,053 F1 · security: The grant of the Issuer's restricted common stock was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The shares of restricted common stock are fully vested. F2 · shares: Gives effect to a reverse stock split of 1-for-40 effective March 27, 2025. F2 · balance_after: Gives effect to a reverse stock split of 1-for-40 effective March 27, 2025. F3 · balance_after: The amount beneficially owned will not reconcile to prior Form 4s due to a scriveners error. Read SEC document |
| February 26, 2024 Filed Mar 7, 2024 22:30 UTC |
Paglia John KennethDirector
|
GrantStock options · Derivative | 600,000 | $0.00 Strike: $0.53 | $0.00 |
DisclosureSEC source: 0001731122-24-000375 · ownership.xml · derivative · entry 1 Paglia John Kenneth · CIK 0001627832 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 600,000 Underlying: Common stock · 600,000 shares Expires 2034-02-26 F1 · kind: The options were issued in connection with serving as a director on SBEV's board, pursuant to the 2020 Long-Term Incentive Compensation Plan. The options are subject to the following vesting schedule: (i) 200,000 shares vested upon execution of Dr. Paglia's offer letter, and (ii) the remaining 400,000 shares vesting 50,000 per quarter beginning May 23, 2024, and ending February 25, 2026. Should there be a change in control of the Company, the options will all immediately vest. F2 · kind: Dr. Paglia's shares remain subject to termination in the event Dr. Paglia chooses to resign during the first 90 days of his tenure. F1 · shares: The options were issued in connection with serving as a director on SBEV's board, pursuant to the 2020 Long-Term Incentive Compensation Plan. The options are subject to the following vesting schedule: (i) 200,000 shares vested upon execution of Dr. Paglia's offer letter, and (ii) the remaining 400,000 shares vesting 50,000 per quarter beginning May 23, 2024, and ending February 25, 2026. Should there be a change in control of the Company, the options will all immediately vest. F2 · shares: Dr. Paglia's shares remain subject to termination in the event Dr. Paglia chooses to resign during the first 90 days of his tenure. F1 · derivative.exercise_date: The options were issued in connection with serving as a director on SBEV's board, pursuant to the 2020 Long-Term Incentive Compensation Plan. The options are subject to the following vesting schedule: (i) 200,000 shares vested upon execution of Dr. Paglia's offer letter, and (ii) the remaining 400,000 shares vesting 50,000 per quarter beginning May 23, 2024, and ending February 25, 2026. Should there be a change in control of the Company, the options will all immediately vest. F2 · derivative.expiration_date: Dr. Paglia's shares remain subject to termination in the event Dr. Paglia chooses to resign during the first 90 days of his tenure. F3 · derivative.expiration_date: The expiration date of the options is fixed at 2/26/2034 and is unaffected whether or not Dr. Paglia is engaged with the Company. Read SEC document |
| June 16, 2023 Filed Jun 16, 2023 15:19 UTC |
Nistico RobertDirector · CEO and Chairman
|
PurchaseCommon Stock | 7,000 | $1.01 | $7,070.00 |
DisclosureSEC source: 0001731122-23-001152 · ownership.xml · nonDerivative · entry 1 Nistico Robert · CIK 0001797597 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,386,000 Read SEC document |
| May 02, 2023 Filed Aug 3, 2023 17:41 UTC |
Wall Ronald CharlesChief Financial Officer
|
GrantStock options · Derivative | 222,000 | $0.00 Strike: $1.21 | $0.00 |
DisclosureSEC source: 0001731122-23-001343 · ownership.xml · derivative · entry 1 Wall Ronald Charles · CIK 0001925305 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 333,000 Underlying: Common stock · 222,000 shares Expires 2033-05-02 F1 · derivative.exercise_date: The options are being issued in connection with serving as the chief financial officer of SBEV, pursuant to the 2020 Long-Term Incentive Compensation Plan. 166,500 of the options vested on May 2, 2023 and 55,500 options will vest on May 2, 2024. Read SEC document |
| May 01, 2023 Filed May 19, 2023 18:06 UTC |
Caple Frederick WilliamDirector
|
GrantStock options · Derivative | 125,000 | $0.00 Strike: $1.26 | $0.00 |
DisclosureSEC source: 0001731122-23-000987 · ownership.xml · derivative · entry 1 Caple Frederick William · CIK 0001978199 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By SNS Universal Solutions, LLC Disclosed balance after: 125,000 Underlying: Common stock · 125,000 shares Expires 2033-05-01 F1 · derivative.exercise_date: The options are being issued in connection with serving on the board of directors of SBEV, pursuant to the 2020 Long-Term Incentive Compensation Plan. 10,417 options will vest on the 1st day of each month starting June 2023 until January 2024 and 10,416 options will vest on the 1st day of each month starting February 2024 until May 2024. F2 · ownership.nature: The Stock Options are issued to SNS Universal Solutions, LLC of which Frederick William Caple is the principle. Read SEC document |
| April 24, 2023 Filed May 15, 2023 16:30 UTC |
Crawford CandaceDirector
|
GrantStock options · Derivative | 125,000 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001731122-23-000934 · ownership.xml · derivative · entry 1 Crawford Candace · CIK 0001864097 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common stock · 125,000 shares Expires 2033-04-05 F1 · derivative.exercise_date: The options are being issued in connection with serving on the board of directors of SBEV, pursuant to the 2020 Long-Term Incentive Compensation Plan. 10,417 options will vest on the 5th day of each month starting May 2023 until December 2023 and 10,416 options will vest on the 5th day of each month starting January 2024 until April 2024. Read SEC document |
| April 24, 2023 Filed May 15, 2023 20:30 UTC |
Yorke Justin WDirector
|
GrantStock options · Derivative | 125,000 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001731122-23-000935 · ownership.xml · derivative · entry 1 Yorke Justin W · CIK 0001361896 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common stock · 125,000 shares Expires 2033-04-05 F1 · derivative.exercise_date: The options are being issued in connection with serving on the board of directors of SBEV, pursuant to the 2020 Long-Term Incentive Compensation Plan. 10,417 options will vest on the 5th day of each month starting May 2023 until December 2023 and 10,416 options will vest on the 5th day of each month starting January 2024 until April 2024. Read SEC document |
| April 24, 2023 Filed May 15, 2023 20:31 UTC |
McDonough Peter JDirector
|
GrantStock options · Derivative | 125,000 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001731122-23-000936 · ownership.xml · derivative · entry 1 McDonough Peter J · CIK 0001680728 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common stock · 125,000 shares Expires 2033-04-05 F1 · derivative.exercise_date: The options are being issued in connection with serving on the board of directors of SBEV, pursuant to the 2020 Long-Term Incentive Compensation Plan. 10,417 options will vest on the 5th day of each month starting May 2023 until December 2023 and 10,416 options will vest on the 5th day of each month starting January 2024 until April 2024. Read SEC document |
| April 14, 2023 Filed Apr 14, 2023 14:34 UTC |
Nistico RobertDirector · CEO and Chairman
|
PurchaseCommon Stock | 12,000 | $1.15 | $13,788.00 |
DisclosureSEC source: 0001731122-23-000653 · ownership.xml · nonDerivative · entry 1 Nistico Robert · CIK 0001797597 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,379,000 Read SEC document |
| April 13, 2023 Filed Apr 13, 2023 16:48 UTC |
Nistico RobertDirector · CEO and Chairman
|
PurchaseCommon Stock | 10,000 | $1.17 | $11,699.00 |
DisclosureSEC source: 0001731122-23-000644 · ownership.xml · nonDerivative · entry 2 Nistico Robert · CIK 0001797597 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,367,000 Read SEC document |
| April 13, 2023 Filed Apr 13, 2023 16:48 UTC |
Nistico RobertDirector · CEO and Chairman
|
PurchaseCommon Stock | 7,000 | $1.17 | $8,183.00 |
DisclosureSEC source: 0001731122-23-000644 · ownership.xml · nonDerivative · entry 1 Nistico Robert · CIK 0001797597 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,357,000 Read SEC document |
| June 16, 2022 Filed Jun 16, 2022 21:04 UTC |
Nistico RobertDirector · CEO and Chairman
|
PurchaseCommon Stock | 1,000 | $1.69 | $1,690.00 |
DisclosureSEC source: 0001731122-22-001089 · ownership.xml · nonDerivative · entry 5 Nistico Robert · CIK 0001797597 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,327,070 Read SEC document |
| June 16, 2022 Filed Jun 16, 2022 21:04 UTC |
Nistico RobertDirector · CEO and Chairman
|
PurchaseCommon Stock | 1,000 | $1.67 | $1,670.00 |
DisclosureSEC source: 0001731122-22-001089 · ownership.xml · nonDerivative · entry 4 Nistico Robert · CIK 0001797597 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,326,070 Read SEC document |
| June 16, 2022 Filed Jun 16, 2022 21:04 UTC |
Nistico RobertDirector · CEO and Chairman
|
PurchaseCommon Stock | 1,000 | $1.69 | $1,690.00 |
DisclosureSEC source: 0001731122-22-001089 · ownership.xml · nonDerivative · entry 3 Nistico Robert · CIK 0001797597 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,325,070 Read SEC document |
| June 15, 2022 Filed Jun 16, 2022 21:04 UTC |
Nistico RobertDirector · CEO and Chairman
|
PurchaseCommon Stock | 685 | $1.83 | $1,253.55 |
DisclosureSEC source: 0001731122-22-001089 · ownership.xml · nonDerivative · entry 2 Nistico Robert · CIK 0001797597 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,324,070 Read SEC document |
| June 15, 2022 Filed Jun 16, 2022 21:04 UTC |
Nistico RobertDirector · CEO and Chairman
|
PurchaseCommon Stock | 315 | $1.82 | $573.30 |
DisclosureSEC source: 0001731122-22-001089 · ownership.xml · nonDerivative · entry 1 Nistico Robert · CIK 0001797597 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,323,385 Read SEC document |
| June 03, 2022 Filed Jun 7, 2022 13:09 UTC |
Nistico RobertDirector · CEO and Chairman
|
PurchaseCommon Stock | 1,000 | $2.07 | $2,070.00 |
DisclosureSEC source: 0001731122-22-001037 · ownership.xml · nonDerivative · entry 2 Nistico Robert · CIK 0001797597 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,323,070 Read SEC document |
| June 03, 2022 Filed Jun 7, 2022 13:09 UTC |
Nistico RobertDirector · CEO and Chairman
|
PurchaseCommon Stock | 1,000 | $2.04 | $2,040.00 |
DisclosureSEC source: 0001731122-22-001037 · ownership.xml · nonDerivative · entry 1 Nistico Robert · CIK 0001797597 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,322,070 Read SEC document |
| May 27, 2022 Filed May 31, 2022 20:05 UTC |
Nistico RobertDirector · CEO and Chairman
|
PurchaseCommon Stock | 1,000 | $2.04 | $2,040.00 |
DisclosureSEC source: 0001731122-22-001019 · ownership.xml · nonDerivative · entry 7 Nistico Robert · CIK 0001797597 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,321,070 Read SEC document |
| May 27, 2022 Filed May 31, 2022 20:05 UTC |
Nistico RobertDirector · CEO and Chairman
|
PurchaseCommon Stock | 1,000 | $2.03 | $2,030.00 |
DisclosureSEC source: 0001731122-22-001019 · ownership.xml · nonDerivative · entry 6 Nistico Robert · CIK 0001797597 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,320,070 Read SEC document |
| May 27, 2022 Filed May 31, 2022 20:05 UTC |
Nistico RobertDirector · CEO and Chairman
|
PurchaseCommon Stock | 2,000 | $2.12 | $4,240.00 |
DisclosureSEC source: 0001731122-22-001019 · ownership.xml · nonDerivative · entry 5 Nistico Robert · CIK 0001797597 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,319,070 Read SEC document |
| May 26, 2022 Filed May 31, 2022 20:05 UTC |
Nistico RobertDirector · CEO and Chairman
|
PurchaseCommon Stock | 2,000 | $1.95 | $3,900.00 |
DisclosureSEC source: 0001731122-22-001019 · ownership.xml · nonDerivative · entry 4 Nistico Robert · CIK 0001797597 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,317,070 Read SEC document |
| May 26, 2022 Filed May 31, 2022 20:05 UTC |
Nistico RobertDirector · CEO and Chairman
|
PurchaseCommon Stock | 2,000 | $1.95 | $3,900.00 |
DisclosureSEC source: 0001731122-22-001019 · ownership.xml · nonDerivative · entry 3 Nistico Robert · CIK 0001797597 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,315,070 Read SEC document |
| May 26, 2022 Filed May 31, 2022 20:05 UTC |
Nistico RobertDirector · CEO and Chairman
|
PurchaseCommon Stock | 2,000 | $1.99 | $3,980.00 |
DisclosureSEC source: 0001731122-22-001019 · ownership.xml · nonDerivative · entry 2 Nistico Robert · CIK 0001797597 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,313,070 Read SEC document |
| May 26, 2022 Filed May 31, 2022 20:05 UTC |
Nistico RobertDirector · CEO and Chairman
|
PurchaseCommon Stock | 1,000 | $1.94 | $1,940.00 |
DisclosureSEC source: 0001731122-22-001019 · ownership.xml · nonDerivative · entry 1 Nistico Robert · CIK 0001797597 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,311,070 Read SEC document |
| May 02, 2022 Filed Jan 31, 2023 20:18 UTC |
Wall Ronald CharlesChief Financial Officer
|
GrantOption (Right to Buy) · Derivative | 111,000 | $0.00 Strike: $2.31 | $0.00 |
DisclosureSEC source: 0001731122-23-000105 · ownership.xml · derivative · entry 1 Wall Ronald Charles · CIK 0001925305 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,000 Underlying: Common Stock · 111,000 shares Expires 2032-05-02 F1 · derivative.exercise_date: One-fourth of the Options vested on May 2, 2022. One-fourth of the Options will vest on May 2, 2023, May 2, 2024, and May 2, 2025. Read SEC document |
| May 02, 2022 Filed Oct 16, 2023 21:54 UTC |
Dhalla FatimaInterim CFO
|
GrantStock options · Derivative | 35,000 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001731122-23-001907 · ownership.xml · derivative · entry 1 Dhalla Fatima · CIK 0001913908 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Common stock · 35,000 shares Expires 2032-05-02 F1 · derivative.exercise_date: The options were issued in connection with serving as the interim chief financial officer of SBEV, pursuant to the 2020 Long-Term Incentive Compensation Plan. All 35,000 options vested on May 2, 2022. Read SEC document |
| September 30, 2021 Filed Mar 31, 2022 21:44 UTC |
Crawford CandaceDirector
|
GrantOption (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $2.60 | $0.00 |
DisclosureSEC source: 0001731122-22-000657 · ownership.xml · derivative · entry 1 Crawford Candace · CIK 0001864097 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2026-09-30 F1 · derivative.exercise_date: Two-thirds of the Options vested on September 30, 2021, and one-third of the Options vest on September 30, 2022. Read SEC document |
| September 30, 2021 Filed Apr 1, 2022 01:42 UTC |
Yorke Justin WDirector
|
GrantOption (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $2.60 | $0.00 |
DisclosureSEC source: 0001731122-22-000655 · ownership.xml · derivative · entry 1 Yorke Justin W · CIK 0001361896 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2026-09-30 F1 · derivative.exercise_date: Two-thirds of the Options vested on September 30, 2021, and one-third of the Options vest on September 30, 2022. Read SEC document |
| September 30, 2021 Filed Apr 1, 2022 01:39 UTC |
Nistico RobertDirector · CEO, President and Chairman
|
GrantOption (Right to Buy) · Derivative | 530,000 | $0.00 Strike: $2.60 | $0.00 |
DisclosureSEC source: 0001731122-22-000653 · ownership.xml · derivative · entry 1 Nistico Robert · CIK 0001797597 · Director · CEO, President and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 530,000 Underlying: Common Stock · 530,000 shares Expires 2026-09-30 F1 · derivative.exercise_date: Two-thirds of the Options vested on September 30, 2021, and one-third of the Options vest on September 30, 2022. Read SEC document |
| September 30, 2021 Filed Apr 1, 2022 01:37 UTC |
McDonough Peter JDirector
|
GrantOption (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $2.60 | $0.00 |
DisclosureSEC source: 0001731122-22-000651 · ownership.xml · derivative · entry 1 McDonough Peter J · CIK 0001680728 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2026-09-30 F1 · derivative.exercise_date: Two-thirds of the Options vested on September 30, 2021, and one-third of the Options vest on September 30, 2022. Read SEC document |
| May 16, 2021 Filed Apr 5, 2022 17:25 UTC |
Crawford CandaceDirector
|
GrantOption (Right to Buy) · Derivative | 333,333 | $0.00 Strike: $2.25 | $0.00 |
DisclosureSEC source: 0001731122-22-000676 · ownership.xml · derivative · entry 1 Crawford Candace · CIK 0001864097 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333,333 Underlying: Common Stock · 333,333 shares Expires 2026-05-15 F1 · derivative.exercise_date: One-third of the Options vested immediately, one-third of the Options vested on May 15, 2021, and one-third of the Options vest on May 15, 2022. Read SEC document |
| October 16, 2020 Filed Oct 19, 2020 22:30 UTC |
Yorke Justin WDirector
|
GrantWarrants (Right to Buy) · Derivative | 166,666 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001731122-20-001059 · ownership.xml · derivative · entry 3 Yorke Justin W · CIK 0001361896 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,666 Underlying: Common Stock · 166,666 shares Expires 2027-10-15 F1 · price: Not applicable Read SEC document |
| October 16, 2020 Filed Oct 19, 2020 22:30 UTC |
Yorke Justin WDirector
|
GrantWarrants (Right to Buy) · Derivative | 166,667 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001731122-20-001059 · ownership.xml · derivative · entry 2 Yorke Justin W · CIK 0001361896 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,667 Underlying: Common Stock · 166,667 shares Expires 2026-10-15 F1 · price: Not applicable Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.